US breast implant firms in public attack over product standards and procedures:
This article was originally published in Clinica
Executive Summary
Five women's groups seeking to block silicone breast implants from entering the US market have shifted their attention to reports that Mentor hid data from the FDA about product defects. The groups base their claim on a recent story in the New York Times, which detailed a 2003 court deposition of two former Mentor employees.